Clinical Evaluation Report MDR Requirements
It is the
process to generate clinical evidence to establish the safety and efficacy
applicable to all the classes of medical devices. The Clinical Evaluation
should be drafted with the help of MEDDEV 2.7/1 Rev. 4, using MDCG Guidelines
(MDCG 2020-1, MDCG 2020-6, MDCG 2020-13, IMDRF MDCE WG/N56FINAL:2019 and Annex
XIV, Article 61 of EU MDR)
The legal
manufacturer must draft the Clinical Evaluation Report (CER) in compliance with
General Safety and Performance Requirements (GSPR) Checklist. The aim of a CER
is to reduce the risk that the users and patients are exposed to when using a
medical device.
The
final Clinical Evaluation Report (CER) will summaries:
1. Device description and intended use
of the product. The purpose of CER is to collect, appraise and analyze the
clinical data obtained from literature searches for the safety and effective
performance of the device.
2. The text articles obtained from
literature searches that includes all the clinical indications, similar
devices, clinical benefits, and medical alternatives with the statistical
significance. It will also capture the literature search results for the
subject device filtered from the defined appraisal criteria. The clinical data
constitutes of alternative medical treatment options, risk situations,
lifetime, clinical benefits, clinical indications for similar and equivalent
devices, adverse event reporting databases, medical device recalls, field
safety notice generated, and field safety corrective actions performed for the
device, similar, benchmark and equivalent devices.
3. The safety and performance of the
device mentioning all the risk situations derived from literatures as an input
to the risk files, how to apply the appropriate control measures, how to
mitigate the risks as far as possible making sure no residual risk remains. If
any residual risk exists, it should be mentioned in the Instruction for Use
(IFU) as a warning or contraindication.
4. Pre-clinical testing performed as
per the applicable standards. The compliance of CER with the GSPR requirements
is summed up. All the complaints obtained from post-market surveillance is
identified for quantitative summation. The post-market clinical follow-up
activity, if any, including ethical committee approval, patient consent form,
sample size, statistical analysis, side effects or any risks encountered,
corrective and preventive actions performed is summarized. The clinical
investigation required for any novel device and the Clinical Development Plan
is drafted, if any clinical study is performed.
Finally,
conclude CER for safety and effective performance of the device and its
compliance with GSPR.
IZiel provides a unique solution developing Clinical Evaluation Plan
(CEP), Clinical Evaluation Report (CER) and thereafter provide the physician’s
certificate. Our partners have a network of 40+ National Board-Certified
Physicians that conduct the risk-benefit analysis and provide the necessary
certification.
Comments
Post a Comment